Cigna Investments Inc. New bought a new stake in Dun & Bradstreet Corporation (The) (NYSE:DNB) during the second quarter, Holdings Channel reports. The firm bought 7,308 shares of the business services provider’s stock, valued at approximately $790,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Texas Permanent School Fund raised its position in shares of Dun & Bradstreet Corporation (The) by 150.4% in the second quarter. Texas Permanent School Fund now owns 26,939 shares of the business services provider’s stock valued at $2,913,000 after buying an additional 16,179 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Dun & Bradstreet Corporation (The) by 43.5% in the second quarter. Bessemer Group Inc. now owns 1,285,064 shares of the business services provider’s stock valued at $138,981,000 after buying an additional 389,334 shares in the last quarter. Cambiar Investors LLC raised its position in shares of Dun & Bradstreet Corporation (The) by 4.8% in the second quarter. Cambiar Investors LLC now owns 35,730 shares of the business services provider’s stock valued at $3,864,000 after buying an additional 1,645 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. raised its position in shares of Dun & Bradstreet Corporation (The) by 22.6% in the second quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 19,150 shares of the business services provider’s stock valued at $2,071,000 after buying an additional 3,530 shares in the last quarter. Finally, Great West Life Assurance Co. Can raised its position in shares of Dun & Bradstreet Corporation (The) by 20.8% in the second quarter. Great West Life Assurance Co. Can now owns 30,239 shares of the business services provider’s stock valued at $3,268,000 after buying an additional 5,205 shares in the last quarter. 92.33% of the stock is owned by institutional investors and hedge funds.

Shares of Dun & Bradstreet Corporation (DNB) opened at 111.62 on Friday. The firm’s 50-day moving average price is $109.30 and its 200-day moving average price is $108.88. Dun & Bradstreet Corporation has a one year low of $100.46 and a one year high of $139.86. The firm has a market capitalization of $4.13 billion, a P/E ratio of 38.00 and a beta of 1.22.

Dun & Bradstreet Corporation (The) (NYSE:DNB) last posted its quarterly earnings results on Wednesday, August 2nd. The business services provider reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.24. The business had revenue of $408.40 million during the quarter, compared to the consensus estimate of $410.90 million. Dun & Bradstreet Corporation (The) had a net margin of 6.36% and a negative return on equity of 26.85%. The firm’s revenue for the quarter was up 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 earnings per share. On average, equities analysts forecast that Dun & Bradstreet Corporation will post $7.04 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Shareholders of record on Wednesday, August 23rd will be paid a $0.5025 dividend. This represents a $2.01 annualized dividend and a yield of 1.80%. The ex-dividend date is Monday, August 21st. Dun & Bradstreet Corporation (The)’s dividend payout ratio is presently 68.37%.

ILLEGAL ACTIVITY NOTICE: “Cigna Investments Inc. New Buys Shares of 7,308 Dun & Bradstreet Corporation (The) (NYSE:DNB)” was reported by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/13/cigna-investments-inc-new-buys-shares-of-7308-dun-bradstreet-corporation-the-nysednb.html.

Several brokerages recently issued reports on DNB. Zacks Investment Research raised Dun & Bradstreet Corporation (The) from a “hold” rating to a “buy” rating and set a $127.00 target price for the company in a research report on Monday, August 7th. BidaskClub raised Dun & Bradstreet Corporation (The) from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. Dun & Bradstreet Corporation (The) has an average rating of “Hold” and an average price target of $117.33.

About Dun & Bradstreet Corporation (The)

The Dun & Bradstreet Corporation is the source of commercial data, analytics and insight on businesses. The Company operates through two segments: Americas, which consists of its operations in the United States and Canada, and Non-Americas, which consists of its operations in the United Kingdom, Greater China, India, and its European and Asia Pacific Worldwide Networks.

Want to see what other hedge funds are holding DNB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dun & Bradstreet Corporation (The) (NYSE:DNB).

Institutional Ownership by Quarter for Dun & Bradstreet Corporation (The) (NYSE:DNB)

Receive News & Ratings for Dun & Bradstreet Corporation (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dun & Bradstreet Corporation (The) and related companies with MarketBeat.com's FREE daily email newsletter.